Gerry M Raghoebar1, Pieter Onclin1, G Carina Boven1, Arjan Vissink1, Henny J A Meijer1,2. 1. Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. 2. Department of Implant Dentistry, Dental School, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
AIM: To assess the long-term effectiveness (≥5 years) of maxillary sinus floor augmentation (MSFA) procedures applying the lateral window technique and to determine possible differences in outcome between simultaneous and delayed implant placement, partially and fully edentulous patients and grafting procedures. MATERIALS AND METHODS: MEDLINE (1950-May 2018), EMBASE (1966-May 2018) and Cochrane Central Register of Controlled Trials (1800-May 2018) were searched. Inclusion criteria were prospective studies with follow-up ≥5 years and a residual bone height ≤6 mm. Outcome measures included implant loss, peri-implant bone level change, suprastructure survival, patient-reported outcome measures and overall complications. Data were pooled and analysed using a random effects model. RESULTS: Out of 2,873 selected articles, 11 studies fulfilled all inclusion criteria. Meta-analysis revealed a weighted annual implant loss of 0.43% (95% CI: 0.37%-0.49%). Meta-regression analysis did not reveal significant differences in implant loss neither between edentulous and dentate patients nor implants placed simultaneously with or delayed after MSFA, nor implants placed in MSFA using solely autologous bone or bone substitutes. The results of the other outcome measures were favourable, and overall complications were low. CONCLUSION: MSFA is a reliable procedure in the partially and fully edentulous maxilla for support of dental implants.
AIM: To assess the long-term effectiveness (≥5 years) of maxillary sinus floor augmentation (MSFA) procedures applying the lateral window technique and to determine possible differences in outcome between simultaneous and delayed implant placement, partially and fully edentulouspatients and grafting procedures. MATERIALS AND METHODS: MEDLINE (1950-May 2018), EMBASE (1966-May 2018) and Cochrane Central Register of Controlled Trials (1800-May 2018) were searched. Inclusion criteria were prospective studies with follow-up ≥5 years and a residual bone height ≤6 mm. Outcome measures included implant loss, peri-implant bone level change, suprastructure survival, patient-reported outcome measures and overall complications. Data were pooled and analysed using a random effects model. RESULTS: Out of 2,873 selected articles, 11 studies fulfilled all inclusion criteria. Meta-analysis revealed a weighted annual implant loss of 0.43% (95% CI: 0.37%-0.49%). Meta-regression analysis did not reveal significant differences in implant loss neither between edentulous and dentate patients nor implants placed simultaneously with or delayed after MSFA, nor implants placed in MSFA using solely autologous bone or bone substitutes. The results of the other outcome measures were favourable, and overall complications were low. CONCLUSION: MSFA is a reliable procedure in the partially and fully edentulous maxilla for support of dental implants.
Authors: Bálint Trimmel; Noémi Gede; Péter Hegyi; Zsolt Szakács; Gyöngyi Anna Mezey; Eszter Varga; Márton Kivovics; Lilla Hanák; Zoltán Rumbus; György Szabó Journal: Clin Oral Implants Res Date: 2021-01-06 Impact factor: 5.977
Authors: Sameh Attia; Clara Narberhaus; Heidrun Schaaf; Philipp Streckbein; Jörn Pons-Kühnemann; Christian Schmitt; Friedrich Wilhelm Neukam; Hans-Peter Howaldt; Sebastian Böttger Journal: J Clin Med Date: 2020-02-01 Impact factor: 4.241